DNTH vs MTCH · rev $6.2M vs P/E 13, rev $3.48B
Dianthus Therapeutics Inc. (DNTH) versus Match Group Inc (MTCH) — a side-by-side from cached financials, not a winner call.
Dianthus Therapeutics Inc. (DNTH) is a biotechnology company listed on US.
Match Group Inc (MTCH) is a internet content & information company listed on NASDAQ.
Latest reported DNTH revenue for 2024-12-31 was $6.2M. Net income was -$85.0M. Revenue was up 120.6% from 2023-12-31 to 2024-12-31. DNTH currently screens at market cap $4.40B.
Latest reported MTCH revenue for 2024-12-31 was $3.48B. Net income was $551.3M. Revenue was up 3.4% from 2023-12-31 to 2024-12-31. MTCH currently screens at market cap $8.24B and trailing P/E 13.5.
DNTH currently screens at market cap $4.40B. MTCH currently screens at market cap $8.24B and trailing P/E 13.5.
Not investment advice. Open the DNTH and MTCH stock pages for the full models.
Not investment advice.